Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease
Author: Gilli, SC
De Paula, EV
Biscaro, FP
Marques, JF
Costa, FF
Saad, ST
Abstract: Objective: To evaluate the effects of prophylactic transfusion by means of erythrocytapheresis at the beginning of the third trimester of pregnancy in women with sickle cell disease (SCD). Methods: A cohort of 14 pregnant women with SCD who received prophylactic erythrocytapheresis transfusions at the beginning of the third trimester was retrospectively compared with a cohort of 17 pregnant women who received simple prophylactic transfusions for no indication other than SCD severity. Results: Prophylactic erythrocytapheresis transfusions were associated with a tower risk of intrauterine growth restriction (OR, 0.11; 95% confidence interval, 0.01-1.00) and oligohydramnios (OR, 0.65; 95% confidence interval, 0.45-0.92) in pregnant women with SCD. Conclusion: These results suggest that erythrocytapheresis transfusions are beneficial in women with SCD)who are in the third trimester of pregnancy. Given the decrease in transfusion risks, this therapy deserves further evaluation in future trials. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. AR rights reserved.
Subject: sickle cell disease
Country: Irlanda
Editor: Elsevier Ireland Ltd
Citation: International Journal Of Gynecology & Obstetrics. Elsevier Ireland Ltd, v. 96, n. 1, n. 8, n. 11, 2007.
Rights: fechado
Identifier DOI: 10.1016/j.ijgo.2006.09.017
Date Issue: 2007
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000244165000008.pdf117.56 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.